Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eda Capkin"'
Autor:
Busra Gurel, Melike Berksoz, Eda Capkin, Ayhan Parlar, Meltem Corbacioglu Pala, Aylin Ozkan, Yılmaz Capan, Duygu Emine Daglikoca, Meral Yuce
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1571 (2022)
Avastin® is a humanized recombinant monoclonal antibody used to treat cancer by targeting VEGF-A to inhibit angiogenesis. SIMAB054, an Avastin® biosimilar candidate developed in this study, showed a different charge variant profile than its innovat
Externí odkaz:
https://doaj.org/article/d639b8ba82f649c6b9f86058a8458ef5
Autor:
Eda Capkin, Hasan Kurt, Busra Gurel, Dilan Bicak, Sibel Akgun Bas, Duygu Emine Daglikoca, Meral Yuce
Publikováno v:
Langmuir. 38:14623-14634
Fc γreceptors (FcγRs) are one of the structures that can initiate effector function for monoclonal antibodies. FcγRIa has the highest affinity toward IgG1-type monoclonal antibodies among all FcγRs. In this study, a comprehensive characterization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d094269bfe242eb9392dde01da77d3d
https://doi.org/10.1021/acs.langmuir.2c02022
https://doi.org/10.1021/acs.langmuir.2c02022
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e19469- (2023)
The controlled orientation of biomolecules on the sensor surface is crucial for achieving high sensitivity and accurate detection of target molecules in biosensing. FcγRI is an immune cell surface receptor for recognizing IgG-coated targets, such as
Externí odkaz:
https://doaj.org/article/67b7bb81e0bd4aa3aef1753eef503f7c
Autor:
Büşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, Meral Yüce
Publikováno v:
Scientia Pharmaceutica, Vol 90, Iss 2, p 36 (2022)
Bevacizumab is a humanized therapeutic monoclonal antibody used to reduce angiogenesis, a hallmark of cancer, by binding to VEGF-A. Many pharmaceutical companies have developed biosimilars of Bevacizumab in the last decade. The official reports provi
Externí odkaz:
https://doaj.org/article/a00f14c450b247d2a048b9f417756e39